Obituaries

W. Henry Sebrell, director of the National Institutes of Health from 1950 to 1955, died September 29 at his home in Pompano Beach, Fla. He was 91 years old. During Sebrell's tenure, NIH created its $64 million, 500-bed clinical center in Bethesda, Md. Sebrell's research centered on nutrition and vitamins; he published nearly 300 papers. In the 1930s he helped discover the cure for pellagra, a fatal disease caused by a niacin deficiency. Sebrell earned his M.D. from the University of Virginia

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

W. Henry Sebrell, director of the National Institutes of Health from 1950 to 1955, died September 29 at his home in Pompano Beach, Fla. He was 91 years old.

During Sebrell's tenure, NIH created its $64 million, 500-bed clinical center in Bethesda, Md. Sebrell's research centered on nutrition and vitamins; he published nearly 300 papers. In the 1930s he helped discover the cure for pellagra, a fatal disease caused by a niacin deficiency.

Sebrell earned his M.D. from the University of Virginia in 1925, after which he spent more than 30 years with the United States Public Health Service and NIH. He served as assistant surgeon general for USPHS in 1950.

David T. Purtilo, discoverer of a fatal genetic immunodeficiency disease, died September 28 in Naples, Fla. He was 53 years old.

Purtilo, chairman of the pathology-microbiology department at the University of Nebraska Medical Center in Omaha, discovered X- linked ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies